國芯科技(688262.SH):公司在汽車電子芯片方面已推出12條產品線
格隆匯1月6日丨國芯科技(688262.SH)近日在接待機構投資者調研時表示,公司在汽車電子芯片方面已推出12條產品線,包括汽車域控制芯片、輔助駕駛處理芯片、主動降噪專用DSP芯片、動力總成控制芯片、新能源電池管理芯片、線控底盤芯片、車身和網關控制芯片、車聯網安全芯片、儀表及小節點控制芯片、安全氣囊芯片、數模混合信號類芯片和智能傳感芯片等。截至2024年底,汽車域控制、動力總成、線控底盤、車身和網關控制、車聯網安全和安全氣囊點火芯片等領域均實現量產裝車,2025年隨着量產項目的增加,上述領域12條產品線芯片有望進一步獲得量產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.